This inventor holds 3 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: The University of Texas System. Active years: 2015-2019.
Company Filing History:
Years Active: 2015-2019
Title: Jason Lavinder: Innovator in Antibody Identification
Introduction
Jason Lavinder is a prominent inventor based in Round Rock, TX (US). He has made significant contributions to the field of proteomics, particularly in the identification and generation of antibodies. With a total of 3 patents, Lavinder's work has the potential to advance therapeutic and diagnostic applications in medicine.
Latest Patents
Lavinder's latest patents focus on the proteomic identification of antibodies. These patents provide methods and compositions for identifying candidate antigen-specific variable regions. They also detail the generation of antibodies or antigen-binding fragments that exhibit desired antigen specificity. For instance, the patents describe methods for determining amino acid sequences of serum antibody CDR3 and their abundancy levels. Additionally, they include methods for determining nucleic acid sequences of antibody variable region sequences and their frequency in biological samples. The inventions also offer methods for identifying and generating antibodies or antigen-binding fragments that comprise highly-represented CDR domains.
Career Highlights
Jason Lavinder is affiliated with the University of Texas System, where he continues to contribute to research and innovation in the field of antibody identification. His work is instrumental in enhancing our understanding of antibody specificity and its applications in various biological contexts.
Collaborations
Lavinder has collaborated with notable colleagues, including Edward M Marcotte and George Georgiou. These collaborations have further enriched his research and expanded the impact of his inventions.
Conclusion
Jason Lavinder's innovative work in the field of antibody identification showcases his dedication to advancing scientific knowledge and medical applications. His contributions are paving the way for future developments in therapeutic and diagnostic technologies.
